Hit-to-Lead Development of potent broad-spectrum coronavirus fusion inhibitors

Project Information

Inhibicov

Grant agreement ID: 101100758

DOI

10.3030/101100758

Project closed

EC signature date 26 September 2022

Start date 1 November 2022

End date 30 April 2024

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

WEIZMANN INSTITUTE OF SCIENCE
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors

Author(s): Suman Khan, Efrat Ozer Partuk, Jeanne Chiaravalli, Noga Kozer, Khriesto A. Shurrush, Yael Elbaz-Alon, Nadav Scher, Emilie Giraud, Jaouen Tran-Rajau 2, Fabrice Agou, Haim Michael Barr, Ori Avinoam
Published in: iScience, 2024, ISSN 2589-0042
Publisher: Cell Press Elsevier Inc
DOI: 10.1016/J.ISCI.2024.110019